Advisor Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $39K | Buy |
3,765
+2,474
| +192% | +$25.6K | ﹤0.01% | 3576 |
|
2019
Q3 | $4K | Buy |
1,291
+676
| +110% | +$2.1K | ﹤0.01% | 4765 |
|
2019
Q2 | $9K | Buy |
615
+80
| +15% | +$1.17K | ﹤0.01% | 4429 |
|
2019
Q1 | $13K | Hold |
535
| – | – | ﹤0.01% | 4232 |
|
2018
Q4 | $9K | Buy |
535
+110
| +26% | +$1.85K | ﹤0.01% | 4264 |
|
2018
Q3 | $13K | Sell |
425
-328
| -44% | -$10K | ﹤0.01% | 4140 |
|
2018
Q2 | $35K | Sell |
753
-50
| -6% | -$2.32K | ﹤0.01% | 3371 |
|
2018
Q1 | $42K | Sell |
803
-330
| -29% | -$17.3K | ﹤0.01% | 3206 |
|
2017
Q4 | $78K | Sell |
1,133
-8
| -0.7% | -$551 | ﹤0.01% | 2763 |
|
2017
Q3 | $94K | Buy |
1,141
+274
| +32% | +$22.6K | ﹤0.01% | 2463 |
|
2017
Q2 | $82K | Buy |
867
+157
| +22% | +$14.8K | ﹤0.01% | 2474 |
|
2017
Q1 | $46K | Sell |
710
-240
| -25% | -$15.5K | ﹤0.01% | 2788 |
|
2016
Q4 | $42K | Sell |
950
-443
| -32% | -$19.6K | ﹤0.01% | 2750 |
|
2016
Q3 | $50K | Buy |
1,393
+1,221
| +710% | +$43.8K | ﹤0.01% | 2551 |
|
2016
Q2 | $2K | Buy |
+172
| New | +$2K | ﹤0.01% | 4131 |
|